London Daily

Focus on the big picture.
Wednesday, Nov 26, 2025

Oxford Covid vaccine could be approved 'just after Christmas'

Oxford Covid vaccine could be approved 'just after Christmas'

The coronavirus vaccine being developed by Oxford University and AstraZeneca could be approved shortly after Christmas, a medical scientist has said.


Professor Sir John Bell said he expects the Medicines and Healthcare products Regulatory Agency (MRHA) to sign off its approval of the jab ‘pretty shortly’.

Sir John, Oxford University’s regius professor of medicine, told BBC Radio 4’s Today programme: ‘They got data quite a long time ago but that was the first set of data. They receive multiple sets of data.

‘So we are getting to be about prime time now, I would expect some news pretty shortly. I doubt we’ll make Christmas now, but just after Christmas I would expect. I have no concerns whatsoever that the data looks better than ever.’

His comments came as former prime minister Tony Blair called for major policy shifts in the rollout of vaccines, concentrating on giving more people a single dose with greater flexibility in who receives a jab.

Approval of the Oxford vaccine would be a major boost to efforts to control Covid-19 because it is easier to distribute than the Pfizer/BioNTech jab currently being used in the UK.


Approval from regulators is expected shortly after Christmas


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine, with around 40 million available by the end of March.

Health Secretary Matt Hancock told a Downing Street press conference that the Oxford/AstraZeneca team has now submitted full data to the regulator for approval.

He said: ‘This is the next step towards a decision on the deployment of the vaccine which is already being manufactured, including here in the UK.’


The Government has ordered 100 million doses of the Oxford/AstraZeneca vaccine


Mr Blair told Today ‘the reality is we are now in severe lockdown until vaccination’ and so it should be a priority to give as many people as possible some protection.

While ideally people should received the required two doses, the question is: ‘Does the first dose give you substantial immunity, and by that I mean over 50% effectiveness?

‘If it does, there is a very strong case for not, as it were, holding back doses of the vaccine.’


A volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University


For example ‘if, in January, AstraZeneca is delivering you 10 or 20 million doses of the vaccine, you vaccinate 10 or 20 million people’.

Mr Blair went on: ‘You should get more vaccine coming on stream by the time you are ready for the second dose and that first dose can give you substantial immunity.’

The former premier also criticised the ‘somewhat inflexible “by age” structure’ used to determine who receives the jab.


A vial of coronavirus vaccine developed by AstraZeneca and Oxford University


Experts at the Joint Committee on Vaccination and Immunisation have drawn up a priority list based on clinical need.

But Mr Blair, who does not have a medical background, said ‘there is a strong case for saying you have got to focus also on the people spreading the disease, not simply the most vulnerable’.

Communities Secretary Robert Jenrick told Today that the Government is focusing on getting as many people as possible to receive the first dose of the Pfizer vaccine.

He said: ‘At the moment the priority is just to ensure that as many people as possible get the first shot of the vaccine.

‘Remember, the second shot has to be done, depending on what the vaccine is, 21 or 28 days later and so we still haven’t reached that point with the first people who were vaccinated.’

Asked whether the Government would consider dropping the second shot, Mr Jenrick said: ‘The strategy will always be kept under review but the priority today is to ensure that as many people as possible are given the first shot of the vaccine; that is what is happening.’

Newsletter

Related Articles

0:00
0:00
Close
UK Economy Stalls as Reeves Faces First Budget Test
UK Economy’s Weak Start Adds Pressure on Prime Minister Starmer
UK Government Acknowledges Billionaire Exodus Amid Tax Rise Concerns
UK Budget 2025: Markets Brace as Chancellor Faces Fiscal Tightrope
UK Unveils Strategic Plan to Secure Critical Mineral Supply Chains
UK Taskforce Calls for Radical Reset of Nuclear Regulation to Cut Costs and Accelerate Build
UK Government Launches Consultation on Major Overhaul of Settlement Rules
Google Struggles to Meet AI Demand as Infrastructure, Energy and Supply-Chain Gaps Deepen
Car Parts Leader Warns Europe Faces Heavy Job Losses in ‘Darwinian’ Auto Shake-Out
Arsenal Move Six Points Clear After Eze’s Historic Hat-Trick in Derby Rout
Wealthy New Yorkers Weigh Second Homes as the ‘Mamdani Effect’ Ripples Through Luxury Markets
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
UK Unveils Critical-Minerals Strategy to Break China Supply-Chain Grip
Taylor Swift’s “The Fate of Ophelia” Extends U.K. No. 1 Run to Five Weeks
UK VPN Sign-Ups Surge by Over 1,400 % as Age-Verification Law Takes Effect
Former MEP Nathan Gill Jailed for Over Ten Years After Taking Pro-Russia Bribes
Majority of UK Entrepreneurs Regard Government as ‘Anti-Business’, Survey Shows
UK’s Starmer and US President Trump Align as Geneva Talks Probe Ukraine Peace Plan
UK Prime Minister Signals Former Prince Andrew Should Testify to US Epstein Inquiry
Royal Navy Deploys HMS Severn to Shadow Russian Corvette and Tanker Off UK Coast
China’s Wedding Boom: Nightclubs, Mountains and a Demographic Reset
Fugees Founding Member Pras Michel Sentenced to 14 Years in High-Profile US Foreign Influence Case
WhatsApp’s Unexpected Rise Reshapes American Messaging Habits
United States: Judge Dressed Up as Elvis During Hearings – and Was Forced to Resign
Johnson Blasts ‘Incoherent’ Covid Inquiry Findings Amid Report’s Harsh Critique of His Government
Lord Rothermere Secures £500 Million Deal to Acquire Telegraph Titles
Maduro Tightens Security Measures as U.S. Strike Threat Intensifies
U.S. Envoys Deliver Ultimatum to Ukraine: Sign Peace Deal by Thursday or Risk Losing American Support
Zelenskyy Signals Progress Toward Ending the War: ‘One of the Hardest Moments in History’ (end of his business model?)
U.S. Issues Alert Declaring Venezuelan Airspace a Hazard Due to Escalating Security Conditions
The U.S. State Department Announces That Mass Migration Constitutes an Existential Threat to Western Civilization and Undermines the Stability of Key American Allies
Students Challenge AI-Driven Teaching at University of Staffordshire
Pikeville Medical Center Partners with UK’s Golisano Children’s Network to Expand Pediatric Care
Germany, France and UK Confirm Full Support for Ukraine in US-Backed Security Plan
UK Low-Traffic Neighbourhoods Face Rising Backlash as Pandemic Schemes Unravel
UK Records Coldest Night of Autumn as Sub-Zero Conditions Sweep the Country
UK at Risk of Losing International Doctors as Workforce Exodus Grows, Regulator Warns
ASU Launches ASU London, Extending Its Innovation Brand to the UK Education Market
UK Prime Minister Keir Starmer to Visit China in January as Diplomatic Reset Accelerates
Google Launches Voluntary Buyouts for UK Staff Amid AI-Driven Company Realignment
UK braces for freezing snap as snow and ice warnings escalate
Majority of UK Novelists Fear AI Could Displace Their Work, Cambridge Study Finds
UK's Carrier Strike Group Achieves Full Operational Capability During NATO Drill in Mediterranean
Trump and Mamdani to Meet at the White House: “The Communist Asked”
Nvidia Again Beats Forecasts, Shares Jump in After-Hours Trading
Wintry Conditions Persist Along UK Coasts After Up to Seven Centimetres of Snow
UK Inflation Eases to 3.6 % in October, Opening Door for Rate Cut
UK Accelerates Munitions Factory Build-Out to Reinforce Warfighting Readiness
UK Consumer Optimism Plunges Ahead of November Budget
A Decade of Innovation Stagnation at Apple: The Cook Era Critique
×